Moreover, changes in myokine concentrations (e.g., irisin, interleukin-15, and brain-derived neurotrophic factor) may also play a critical role in NAFLD (Pedersen and Febbraio, 2012). This evidence concerns the gene BDNF and metabolic dysfunction-associated steatotic liver disease.